Drug Delivery Devices - Mexico

Mexico

Highlights

Revenue in the Drug Delivery Devices market market in Mexico is anticipated to reach US$351.50m in 2024.
It is forecasted that revenue will exhibit an annual growth rate (CAGR 2024-2029) of 5.22%, leading to a market volume of US$453.40m by 2029.
In a global context, the majority of revenue is expected to be generated the United States, amounting to US$15.01bn in 2024.
In Mexico, the growing emphasis on innovative drug delivery devices is reshaping healthcare accessibility and enhancing patient outcomes amidst evolving regulatory frameworks.

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Drug Delivery Devices Market within the Medical Devices sector in Mexico is experiencing moderate growth, influenced by factors such as increasing healthcare investments, advancements in technology, and the demand for efficient treatment options among patients and providers.

Customer preferences: In Mexico, there is a notable shift towards personalized and convenient drug delivery solutions, as patients increasingly favor devices that simplify their treatment regimens. This trend is influenced by a growing demographic of tech-savvy millennials and Gen Z individuals who prioritize efficiency and ease of use. Additionally, cultural attitudes toward health management are evolving, with a focus on preventive care and self-management, driving demand for innovative delivery devices that enhance adherence and improve outcomes in chronic disease management.

Trends in the market: In Mexico, the Drug Delivery Devices Market is experiencing a significant shift towards user-friendly and personalized solutions, driven by a growing demand for self-management tools among patients. The rise of chronic diseases and an aging population are propelling the need for innovative delivery systems that enhance medication adherence. Additionally, the integration of smart technology in devices, such as app connectivity and real-time monitoring, is becoming increasingly popular. This trend is crucial for industry stakeholders, as it presents opportunities for collaboration, investment in R&D, and the development of targeted marketing strategies to engage tech-savvy consumers.

Local special circumstances: In Mexico, the Drug Delivery Devices Market is shaped by a unique blend of cultural, geographical, and regulatory factors. A significant portion of the population relies on traditional medicine, which influences the acceptance of modern drug delivery systems. Furthermore, the country's diverse terrain poses challenges for logistics and distribution, necessitating innovative solutions for accessibility. Regulatory frameworks are evolving, focusing on improving patient safety and encouraging local manufacturing, which fosters a competitive environment for new technologies. These elements collectively drive the demand for tailored drug delivery devices that cater to the specific needs of Mexican patients.

Underlying macroeconomic factors: The Drug Delivery Devices Market in Mexico is significantly influenced by macroeconomic factors such as economic stability, healthcare funding, and regulatory developments. A robust national economy fosters investment in healthcare infrastructure, enhancing the availability of advanced drug delivery systems. Additionally, government initiatives aimed at improving healthcare access and affordability drive demand for innovative solutions. Fluctuations in global economic conditions, such as trade agreements and currency exchange rates, also impact the import costs of medical devices. Furthermore, increasing healthcare awareness among the population is propelling the need for more effective drug delivery methods, shaping the market landscape.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.